T. Rowe Price reports 7.8% stake in Natera
T. Rowe Price Associates, Inc. reported beneficial ownership of 10,872,702 shares of Natera Inc. common stock, representing 7.8% of the class as of 12/31/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. reported beneficial ownership of 10,872,702 shares of Natera Inc. common stock, representing 7.8% of the class as of 12/31/2025. It has sole voting power over 10,475,212 shares and sole dispositive power over 10,871,989 shares.
The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Natera. It also disclaims being the beneficial owner of the securities, despite filing this Schedule 13G/A amendment.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Natera (NTRA) does T. Rowe Price Associates report?
Why did T. Rowe Price file an amended Schedule 13G/A for Natera (NTRA)?
Does T. Rowe Price intend to influence control of Natera (NTRA)?
How does T. Rowe Price characterize its beneficial ownership of Natera (NTRA)?
What type of reporting person is T. Rowe Price in this Natera (NTRA) filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.